| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 2.219.684 | 7.086.597 | 7.134.086 | 4.739.303 | 2.859.793 | 4.490.950 |
| Total Income - EUR | - | - | - | 0 | 2.219.686 | 7.086.618 | 7.134.106 | 4.739.325 | 2.859.793 | 4.490.952 |
| Total Expenses - EUR | - | - | - | 39 | 2.204.042 | 6.728.822 | 6.815.230 | 4.530.807 | 2.702.847 | 4.252.281 |
| Gross Profit/Loss - EUR | - | - | - | -39 | 15.644 | 357.796 | 318.876 | 208.518 | 156.946 | 238.671 |
| Net Profit/Loss - EUR | - | - | - | -39 | 13.141 | 322.379 | 273.978 | 180.159 | 135.598 | 205.448 |
| Employees | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Beres Pharmaceuticals Private Limited Company Buda
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.438 | 282 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 0 | 2.349.329 | 4.639.411 | 4.491.443 | 3.539.629 | 3.081.610 | 3.789.375 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 1.938.413 | 4.265.134 | 4.346.837 | 3.277.993 | 3.033.741 | 3.669.054 |
| Cash | - | - | - | 0 | 410.916 | 374.276 | 144.607 | 261.636 | 47.868 | 120.321 |
| Shareholders Funds | - | - | - | -39 | 13.103 | 335.233 | 601.777 | 783.804 | 917.025 | 1.117.348 |
| Social Capital | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | - | 39 | 2.337.694 | 4.304.492 | 3.889.745 | 2.756.969 | 2.165.832 | 2.672.080 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Beres Pharmaceuticals Private Limited Company Budapesta Sucursala Sîntana De Mureş